SCOTT WEBSTER: Open Payments
NPI 1275916785 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 59 payments from 12 companies in 2025. Trend: 2023 $717 · 2024 $834 · 2025 $1,107
Food & beverage: $1,008Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $209 |
| ABBVIE INC. | 13 | $173 |
| LEO Pharma Inc. | 8 | $163 |
| PFIZER INC. | 10 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| Organon LLC | 6 | $81 |
| Galderma Laboratories, L.P. | 3 | $54 |
| Lilly USA, LLC | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| UCB, Inc. | 1 | $24 |
Products named: TREMFYA, ADBRY, LITFULO, SKYRIZI, NEMLUVIO, COSENTYX, EBGLYSS, RINVOQ.
Industry payments across UT — which companies pay providers there.
